No subject


Thu Dec 9 03:57:02 EST 2010


Prevention (CDC) issued its first set of evidence-based recommendations
for health care professionals in the US on contraceptive safety. The US
Medical Eligibility Criteria for Contraceptive Use, 2010 offers guidance
to physicians and health care professionals when providing family
planning counseling and services to women, especially to those with
specific existing medical conditions. The CDC recommendations were
adapted from the guidance previously developed by the World Health
Organization and will be regularly updated to reflect the latest
published evidence. The US version adapts some of the guidance for
better alignment with recommendations from ACOG and to better fit the US
health care system. The full recommendations are available at
www.cdc.gov/mmwr (
http://www.acog.org/cgi-shl/leaving.pl?http://www.cdc.gov/mmwr ).
Updates and supporting information for clinicians are available at
http://www.cdc.gov/reproductivehealth/UnintendedPregnancy/USMEC.htm (
http://www.acog.org/cgi-shl/leaving.pl?http://www.cdc.gov/reproductivehealth/UnintendedPregnancy/USMEC.htm
). 
Warning: The U.S. Food and Drug Administration (FDA) is alerting
healthcare professionals not to use certain intravenous (IV) bags of
metronidazole, ondansetron, and ciprofloxacin because of potential
contamination. FDA has received reports of floating matter in IV bags
manufactured by Claris Lifesciences Limited, in Ahmedabad, India.
Microbiological analysis identified the matter in one of the bags as a
Cladosporium mold. Molds of this type can cause infections in
susceptible patients, such as immunocompromised individuals. At this
time, FDA is not aware of any reports of injuries due to administration
of these products. Affected products include any metronidazole,
ondansetron, and ciprofloxacin manufactured by Claris Lifesciences
Limited and sold under the following labels: Claris, Sagent
Pharmaceuticals, Pfizer, West-Ward Pharmaceuticals. To learn more, go
tohttp://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00314Infant
Death Prompts Recall of Ring Slings Made by Sprout Stuff Due to
Suffocation Risk.The U.S. Consumer Product Safety Commission (CPSC), in
cooperation with Sprout Stuff, of Austin, Texas, is announcing the
recall of about 40 Sprout Stuff infant ring slings. CPSC advises
consumers to immediately stop using these slings due to a risk of
suffocation to infants. CPSC and Sprout Stuff are aware of one report of
a death of a 10-day-old boy in the recalled sling in Round Rock, Texas
in 2007. The Sprout Stuff infant ring sling is fabric/natural muslin and
comes with or without a shoulder pad. The sling is worn by parents and
caregivers to carry a child up to two years of age. “Sprout Stuff” is
printed on the back side of the tail’s hem. Sprout Stuff sold the
recalled infant slings, which were made in the United States, directly
to consumers between October 2006 and May 2007 for between $35 and $45.
Sprout Stuff is directly contacting known purchasers of the recalled
infant slings.Consumers should immediately stop using the recalled
slings and contact Sprout Stuff to return the sling for a full refund.
Contact Sprout Stuff toll-free at (877) 319-3103 anytime, email the firm
at sproutstuffrefunds at gmail.comor contact the firm by mail at Sprout
Stuff Refunds, P.O. Box 612, Buda, Texas 78610. Do not attempt to fix
these carriers. For more information or to view the product, goto
http://www.cpsc.gov/cpscpub/prerel/prhtml10/10254.html


More information about the NFIMR mailing list